Tenofovir induced severe thrombocytopenia

doi:10.5497/wjp.v6.i2.11

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 2

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (17623)

All Articles published online

The chart showing PDF series, WORD series, HTML series.

Item

Count

PDF

823

WORD

321

HTML

12592

Sum=13736

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1594

Download

2297

Sum=3891

Jun 9, 2017 (publication date) through Feb 27, 2026

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Case Report

World J Pharmacology. Jun 9, 2017; 6(2): 11-13
Published online Jun 9, 2017. doi: 10.5497/wjp.v6.i2.11

Tenofovir induced severe thrombocytopenia

Mayank Jain, Joy Vargese, Jayanthi Venkatatraman

Mayank Jain, Joy Vargese, Jayanthi Venkatatraman, Institute of Liver Disease and Transplantation, Gleneagles Global Health City, Chennai 600100, India

Author contributions: All authors contributed to the acquisition of data, writing, and revision of this manuscript.

Institutional review board statement: As per institutional policy, we are not required to take Ethical Committee clearance for case reports.

Informed consent statement: As the patient has already given consent for reporting (attached), ethical clearance is not needed. No reports/images disclosing the patient identity have been used in the submission.

Conflict-of-interest statement: The authors do not report any conflict of interest.

Correspondence to: Dr. Mayank Jain, Institute of Liver Disease and Transplantation, Gleneagles Global Health City, Perumbakkam, Chennai 600100, India. mayank4670@rediffmail.com

Telephone: +91-44-24242424 Fax: +91-44-22777100

Received: February 13, 2017
Peer-review started: February 15, 2017
First decision: March 7, 2017
Revised: March 15, 2017
Accepted: April 16, 2017
Article in press: April 17, 2017
Published online: June 9, 2017
Processing time: 102 Days and 7.4 Hours

Abstract

Tenofovir disoproxil fumarate is used in the management of hepatitis B and human immunodeficiency virus infection. We present a 50 years old lady, post liver transplant, who was switched over from entecavir to tenofovir, for management of hepatitis B reactivation. She developed bleeding diathesis and severe thrombocytopenia was detected on investigations. Bone marrow examination showed normocellular marrow with megakaryocytes. Tenofovir was stopped and she was started on intravenous immunoglobulin, followed by steroids. There was improvement in platlet counts. The case highlights a rare side effect of tenofovir therapy.

Keywords: Tenofovir; Hepatitis; Thrombocytopenia

Core tip: The present case report highlights a rare side effect of tenofovir therapy for hepatitis B infection. As the drug is commonly used in for management of hepatitis B and human immunodeficiency virus infection, the knowledge to this rare side effect would help physicians to be more watchful and improve patient management.